ASH 2020 Investor Conference Call: Pioneering the Development of Engineered IgM Antibodies

IGM Investor Conference Call Presentation at the 62nd ASH Annual Meeting and Exposition
December 5, 2020

Fred Schwarzer, CEO; Dan Chen, CSO; Bruce Keyt, CSO; Misbah Tahir, CFO
IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

ASH 2020 Investor Conference Call Presentation

Posted in publications.